Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 837
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
Sarah Cherian, Varsha Potdar, Santosh Jadhav, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1542-1542
Open Access | Times Cited: 632
Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 373
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Jianying Liu, Yang Liu, Hongjie Xia, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 273-275
Open Access | Times Cited: 359
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 278
Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 218
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Coronavirus variants are spreading in India — what scientists know so far
Gayathri Vaidyanathan
Nature (2021) Vol. 593, Iss. 7859, pp. 321-322
Closed Access | Times Cited: 155
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Marion Mafham, Leon Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 140
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 135
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Nina Kreuzberger, Caroline Hirsch, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 9
Open Access | Times Cited: 134
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
Vladimir А. Gushchin, Inna V. Dolzhikova, А. М. Щетинин, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 779-779
Open Access | Times Cited: 114
The Spike of Concern—The Novel Variants of SARS-CoV-2
Anna Winger, Thomas Caspari
Viruses (2021) Vol. 13, Iss. 6, pp. 1002-1002
Open Access | Times Cited: 111
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101533-101533
Open Access | Times Cited: 107
SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
Ziwei Yang, Yang Han, Shilei Ding, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
SARS‐CoV‐2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?
Stefano Pascarella, Massimo Ciccozzi, Davide Zella, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6551-6556
Open Access | Times Cited: 96
SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 95
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
Anusha Nathan, Elizabeth J. Rossin, Clarety Kaseke, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4401-4413.e10
Open Access | Times Cited: 81
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
Uttpal Anand, Shweta Jakhmola, Omkar Indari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 80
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Cell Reports (2021) Vol. 37, Iss. 2, pp. 109825-109825
Open Access | Times Cited: 79
Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies
Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 73
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Aakriti Dubey, Shweta Choudhary, Pravindra Kumar, et al.
Current Microbiology (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 72
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Ali Hamady, JinJu Lee, Zuzanna Loboda
Infection (2021) Vol. 50, Iss. 1, pp. 11-25
Open Access | Times Cited: 68
Covid-19: India sees record deaths as “black fungus” spreads fear
Owen Dyer
BMJ (2021), pp. n1238-n1238
Closed Access | Times Cited: 59
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top